质子束治疗与调强放疗在前列腺癌术后5年临床结局与失败模式的对比分析
单机构回顾性研究纳入2009-2017年接受前列腺床术后放疗患者295例,按3:1匹配后为PBT组65例、IMRT组195例。中位随访59个月,两组生化失败、局部失败、区域失败、远处失败及全因死亡率均无显著差异,失败模式相似。
要点
- 匹配后PBT与IMRT组生化失败率分别为45%与41%,差异无统计学意义。
- 两组局部、区域、远处失败及全因死亡率均无显著差异。
- 失败模式定性相似,远处失败常见骨、腹膜后淋巴结和肺。
核心结论
- 在前列腺癌术后设置中,PBT与IMRT的长期疾病相关结局及失败模式相似。
研究设计与样本
- 单机构回顾性队列研究,纳入2009-2017年接受前列腺床术后IMRT或PBT的患者295例。
- 采用3:1最近邻匹配形成匹配队列,共260例(PBT 65例,IMRT 195例),匹配后仅诊断时年龄存在显著差异(P < .01)。
- 采用多变量Cox比例风险模型估计治疗方式对疾病相关结局的风险比。
主要发现
- 中位随访59个月,PBT组生化失败(机构定义)、局部失败、区域失败、远处失败及死亡率分别为45%(n=29)、2%(n=1)、9%(n=6)、9%(n=6)、2%(n=1)。
- IMRT组对应比率分别为41%(n=80)、3%(n=5)、7%(n=13)、9%(n=18)、5%(n=9),所有比较P > .05。
- 多变量分析显示放疗方式与生化失败(机构或协作组定义)、局部失败(P = .82)、区域失败(P = .11)、远处失败(P = .36)及全因死亡率(P = .69)均无显著关联。
- 两组失败模式定性相似,远处失败部位包括骨、腹膜后淋巴结和肺。
临床怎么用
- 对于前列腺癌术后需行前列腺床放疗的患者,PBT可作为IMRT的替代选择,两者疾病控制结局预期相似。
- 临床决策时可综合考虑两种放疗方式的失败模式相似性,结合患者具体情况选择。
局限性
- 单机构回顾性研究,样本量有限,可能存在选择偏倚。
- 匹配后仅年龄存在显著差异,但未报告其他潜在混杂因素的控制情况。
- 随访时间中位59个月,不足以评估更长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although proton beam therapy (PBT) is a rapidly expanding modality to treat prostate cancer compared with intensity modulated radiation therapy (IMRT), data comparing disease control outcomes and patterns of failure in the postprostatectomy setting remain substantially limited. METHODS AND MATERIALS: All patients who underwent postoperative IMRT or PBT to the prostate bed only at a single institution were included (2009-2017). Endpoints included biochemical failure (BF; using institutional and recent cooperative group trial definitions), local failure (LF), regional failure (RF), distant failure (DF), and all-cause mortality. A case-matched cohort analysis was performed using 3-to-1 nearest-neighbor matching; multivariable Cox proportional hazards modeling (MVA) estimated hazard ratios for disease-related outcomes by treatment modality. RESULTS: Of 295 men, 260 were matched (n = 65 PBT, 195 IMRT); after matching, only age at diagnosis (P < .01) significantly differed between cohorts. At a median follow-up of 59 months, BF (institution-defined), LF, RF, DF, and mortality rates were 45% (n = 29), 2% (n = 1), 9% (n = 6), 9% (n = 6), and 2% (n = 1) for PBT, and 41% (n = 80), 3% (n = 5), 7% (n = 13), 9% (n = 18), and 5% (n = 9) for IMRT (all P > .05). RT modality was not significantly associated with BF on MVA using institutional or cooperative group definitions (all P > .05), nor with LF (P = .82), RF (P = .11), DF (P = .36), or all-cause mortality (P = .69). Patterns of failure were qualitatively similar between cohorts (DF: bone, retroperitoneal nodes, lung). CONCLUSIONS: In this single institution, case-matched analysis, PBT yielded similar long-term disease-related outcomes and patterns of failure to IMRT in the postprostatectomy setting.
引用
- Barsky AR, Carmona R, Verma V, et al. Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy Versus Intensity Modulated Radiation therapy for Prostate Cancer in the Postoperative Setting. Pract Radiat Oncol. 2020. PMID: 33242634. doi:10.1016/j.prro.2020.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。